Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

60
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
60
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.7K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K
Blind Procedures02:07

Blind Procedures

13.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.8K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

313
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
313
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

54
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
54
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

325
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
325

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adults: results from the cross-sectional observational EAGLE study.

BMJ public health·2026
Same author

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study.

Frontiers in pediatrics·2026
Same author

Behavioral pharmacology study to inform the switching potential and abuse liability of tobacco-flavored and menthol-flavored pod-based electronic nicotine delivery systems with 5% nicotine concentration.

Experimental and clinical psychopharmacology·2026
Same author

US adults' complete switching away from cigarettes by menthol- and tobacco-flavored ENDS and by menthol cigarette preference: testing robustness to missing data.

Internal and emergency medicine·2026
Same author

Repeated point-prevalence of switching away from smoking after electronic nicotine delivery systems (ENDS) purchase.

Harm reduction journal·2025
Same author

Assessing the Italian version of the respiratory symptom experience scale (IT-RSES) in smokers and former smokers: a validation study.

BMC public health·2025

Related Experiment Video

Updated: Mar 17, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

13.3K

An acetaminophen icon helps reduce medication decision errors in an experimental setting.

Saul Shiffman, Helene Cotton, Christina Jessurun

    Journal of the American Pharmacists Association : Japha
    |August 1, 2016
    PubMed
    Summary

    An acetaminophen ingredient icon on medication labels significantly reduces medication decision errors by 53%. This visual aid improves safe acetaminophen use, especially for those with limited health literacy.

    More Related Videos

    Errors as a Means of Reducing Impulsive Food Choice
    07:07

    Errors as a Means of Reducing Impulsive Food Choice

    Published on: June 5, 2016

    9.3K
    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
    05:35

    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

    Published on: January 19, 2024

    1.6K

    Related Experiment Videos

    Last Updated: Mar 17, 2026

    Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
    09:38

    Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

    Published on: April 14, 2016

    13.3K
    Errors as a Means of Reducing Impulsive Food Choice
    07:07

    Errors as a Means of Reducing Impulsive Food Choice

    Published on: June 5, 2016

    9.3K
    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
    05:35

    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

    Published on: January 19, 2024

    1.6K

    Area of Science:

    • Consumer Health Decision-Making
    • Medication Safety
    • Health Literacy

    Background:

    • Acetaminophen overdose is a significant cause of liver injury.
    • Current medication labeling may not adequately prevent accidental overdose.
    • Consumers struggle with identifying all acetaminophen-containing products.

    Purpose of the Study:

    • To evaluate the impact of an acetaminophen ingredient icon on medication labels.
    • To assess the icon's effect on consumer decision-making regarding concomitant acetaminophen use.
    • To determine if the icon mitigates risks of acetaminophen overdose and associated liver injury.

    Main Methods:

    • A parallel-group randomized study involving 517 adults.
    • Participants were randomized to either standard labeling or labeling with an acetaminophen icon.
    • Decision-making tasks involved selecting appropriate medications from a simulated medicine cabinet.

    Main Results:

    • The icon reduced medication decision errors by 53%.
    • The icon's benefit was observed across various medication types.
    • The icon improved decisions for individuals with limited health literacy and education, reducing cognitive load.

    Conclusions:

    • An acetaminophen ingredient icon enhances consumer decision-making for acetaminophen-containing medications.
    • The icon is particularly beneficial for individuals with limited health literacy or education.
    • Implementing such icons can improve medication safety and reduce overdose risks.